Fed. Circ. Backs Sequenom Bid To Bar Ariosa Prenatal Test

Law360, New York (August 9, 2013, 4:48 PM EDT) -- The Federal Circuit on Friday gave Sequenom Inc. another chance to obtain a preliminary injunction on an Ariosa Diagnostics Inc. prenatal blood test it claims infringe its patent, finding that a lower court did not properly consider how Ariosa's test could harm Sequenom.

The appeals court vacated U.S. District Judge Susan Illston's July 2012 decision not to impose a preliminary injunction on Ariosa's Harmony test for genetic defects in a fetus, which competes with Sequenom's MaterniT21 test. 

The judge said she denied the injunction in part...
To view the full article, register now.